The Latest and Greatest in Insulin Pumps and Sensor Technology - Taking Control Of Your Diabetes®
FDA Approves Fiasp® For Use In Insulin Pumps for Adults with T1 and T2 Diabetes | dLife
Omnipod + Fiasp is cleared in Europe — JUICEBOX PODCAST
Diabetes Management with Insulin Pumps and CGMs (Continuous Glucose Monitors)
Nonprofit drugmaker will soon sell insulin for $30 a vial, regardless of insurance | WPMI
Guide to Insulin Pens
Frontiers | Real-World Application of Insulin Pump Therapy Among Patients With Type 1 Diabetes in China: A Cross-Sectional Study
Insulin pump therapy can be initiated in primary care
Researchers test an artificial pancreas in outpatients with type 2 diabetes
The biggest diabetes news to come out of ATTD 2022
Health Canada Clears MiniMed 770G Automated Insulin Delivery System
Bionic pancreas improves type 1 diabetes management compared to standard insulin delivery methods | National Institutes of Health (NIH)
Abbott's diabetes deals • Sinai to close subacute unit • Medicare open enrollment | Crain's Chicago Business
Novo Nordisk and Roche' insulin pump system gets EU thumbs up
Treating Type 2 Diabetes | Medtronic
Insulin 100 years
Closed-loop insulin delivery in adults with type 1 diabetes in real-life conditions: a 12-week multicentre, open-label randomised controlled crossover trial - The Lancet Digital Health
Insulin Pumps Edge Injections for T1D Glycemic Control
A Technology Laggard's Foray into Insulin Pumps and Continuous Sensors
Endocrinology Group Calls for Better Insulin-Pump Training
The Pros and Cons of Insulin Pump Therapy | Insulin Nation
ADA Consumer Guide
Treating Type 2 Diabetes | Medtronic
/cdn.vox-cdn.com/uploads/chorus_asset/file/7338033/670GPump_hybridclosedloop.0.png "We finally have an “artificial pancreas” for diabetes. But it's a letdown. - Vox")
We finally have an “artificial pancreas” for diabetes. But it's a letdown. - Vox
